Phenotype analysis of families with TP53 germline variants at the Center for Familial Breast and Ovarian Cancer, Cologne

Documenti analoghi

• BRCA1, BRCA2, and TP53 germline and somatic variants and clinicopathological characteristics of Brazilian patients with epithelial ovarian cancer
  di: Caroline Stahnke Richau, et al.
  Pubblicazione: (2024)
• Transmission ratio distortion of germline TP53 variants in Li–Fraumeni syndrome families
  di: Naama Halpern, et al.
  Pubblicazione: (2025)
• Correction to “Transmission ratio distortion of germline TP53 variants in Li–Fraumeni syndrome families”
  Pubblicazione: (2026)
• A comprehensive study evaluating germline FANCG variants in predisposition to breast and ovarian cancer
  di: Jana Soukupova, et al.
  Pubblicazione: (2024)
• Molecular Characteristics and Treatment Implications of TP53 Gain‐of‐Function Mutations in Non‐Small Cell Lung Cancer
  di: Zheng Zhao, et al.
  Pubblicazione: (2025)